The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia

Cancer Cell International

Volumn 12, Issue , 2012, Pages

  Shen, Qi ^a   Liu, Sichu ^a   Hu, Junyan ^a   Chen, Shaohua ^a   Yang, Lijian ^a   Li, Bo ^a   Wu, Xiuli ^a   Ma, Yu ^a   Yang, Jianchang ^b   Ma, Yupo ^b   Li, Yangqiu ^a  

^a JINAN UNIVERSITY   (China)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

AML; BMI 1 gene; CML; Real time PCR; SALL4 gene

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A3; BMI1 PROTEIN; MEMBRANE PROTEIN; SALL4 PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE OVEREXPRESSION; HUMAN; LEUKEMOGENESIS; MALE; MYELOID LEUKEMIA; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD;

EID: 84867387192     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-12-42     Document Type: Article

References (46)

1. Stams WAG, den Boer ML, Beverloo HB, Meijerink JPP, Stigter RL, van Wering ER, Janka-Schaub GE, Slater R, Pieters R. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. Blood 2003, 101(7):2743-2747. 10.1182/blood-2002-08-2446, 12433682.
2. Miglino M, Colombo N, Pica G, Grasso R, Clavio M, Bergamaschi M, Ballerini F, Ghiso A, Ghiggi C, Mitscheunig L, Beltrami G, Cagnetta A, Vignolo L, Lucchetti MV, Aquino S, Pierri I, Sessarego M, Carella AM, Gobbi M. WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. Leuk Lymphoma 2011, 52(10):1961-1969. 10.3109/10428194.2011.585673, 21942328.
3. Cardoso BA, de Almeida SF, Laranjeira AB, Carmo-Fonseca M, Yunes JA, Coffer PJ, Barata JT. TAL1/SCL is downregulated upon histone deacetylase inhibition in T-cell acute lymphoblastic leukemia cells. Leukemia 2011, 25(10):1578-1586. 10.1038/leu.2011.140, 21647153.
4. Aster JC, Blacklow SC, Pear WS. Notch signalling in T-cell lymphoblastic leukaemia/lymphoma and other haematological malignancies. J Pathol 2011, 223(2):262-273. 2996483, 20967796.
5. Lin C, Zheng H, Wang C, Yang L, Chen S, Li B, Zhou Y, Tan H, Li Y. Mutations increased overexpression of Notch1 in T-cell acute lymphoblastic leukemia. Cancer Cell Int 2012, 12:13. 10.1186/1475-2867-12-13, 3347979, 22480166.
6. Takahashi S. Current findings for recurring mutations in acute myeloid leukemia. J Hematol Oncol 2011, 4:36. 10.1186/1756-8722-4-36, 3180439, 21917154.
7. Braoudaki M, Papathanassiou C, Katsibardi K, Tourkadoni N, Karamolegou K, Tzortzatou-Stathopoulou F. The frequency of NPM1 mutations in childhood acute myeloid leukemia. J Hemotol Oncol 2010, 3:41.
8. Yong AS, Stephens N, Weber G, Li Y, Savani BN, Eniafe R, Keyvanfar K, Kurlander R, Rezvani K, Barrett AJ. Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein. Leukemia 2011, 25(4):629-637. 10.1038/leu.2010.325, 3076540, 21252986.
9. Yang JC, Chai L, Liu F, Fink LM, Lin P, Silberstein LE, Amin HM, Ward DC, Ma YP. Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cells. Proc Natl Acad Sci USA 2007, 104(25):10494-10499. 10.1073/pnas.0704001104, 1965541, 17557835.
10. Kohlhase J, Hausmann S, Stojmenovic G, Dixkens C. Bink Schulz-Schaeffer W, Altmann M, Engel W: SALL3, a new member of the human spalt-like gene family, maps to 18q23. Genomics 1999, 62(2):216-222. 10.1006/geno.1999.6005, 10610715.
11. Al-Baradie R, Yamada K, St Hilaire C, Chan WM, Andrews C, McIntosh N, Nakano M, Martonyi EJ, Raymond WR, Okumura S, Okihiro MM, Engle EC. Duane radial ray syndrome (Okihiro syndrome) maps to 20q13 and results from mutations in SALL4, a new member of the SAL family. Am J Hum Genet 2002, 71(5):1195-1199. 10.1086/343821, 385096, 12395297.
12. Yang J, Aguila JR, Alipio Z, Lai R, Fink LM, Ma Y. Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4. J Hematol Oncol 2011, 4:38. 10.1186/1756-8722-4-38, 3184628, 21943195.
13. Ma YP, Cui W, Yang JC, Qu J, Di CH, Amin HM, Lai R, Ritz J, Krause DS, Chai L. SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood 2006, 108(8):2726-2735. 10.1182/blood-2006-02-001594, 1895586, 16763212.
14. Schuster JA, Stupnikov MR, Ma G, Liao WB, Lai R, Ma YP, Aguila JR. Expansion of hematopoietic stem cells for transplantation: current perspectives. Exp Hematol Oncol 2012, 1:12. 10.1186/2162-3619-1-12, 3514093, 23210618.
15. Jeong HW, Cui W, Yang YY, Lu JY, He J, Li AL, Song D, Guo Y, Liu BH, Chai L. SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes. PLoS One 2011, 6(4):e18372. 10.1371/journal.pone.0018372, 3079717, 21526180.
16. Zink D, Paro R. Drosophila Polycomb-group regulated chromatin inhibits the accessibility of a trans-activator to its target DNA. EMBO J 1995, 14(2):5660-5671. 394681, 8521823.
17. Kennison JA. The Polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function. Annu Rev Genet 1995, 29:289-303. 10.1146/annurev.ge.29.120195.001445, 8825476.
18. Franke A, DeCamillis M, Zink D, Cheng N, Brock HW, Paro R. Polycomb and polyhomeotic are constituents of a multimeric protein complex in chromatin of Drosophila melanogaster. EMBO J 1992, 11(8):2941-2950. 556776, 1353445.
19. Wu J, Hu D, Yang G, Zhou JY, Yang CF, Gao Y, Zhu ZY. Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells. J Cell Bochem 2011, 112(7):1938-1948.
20. Haupt Y, Alexander WS, Barri G, Klinken SP, Adams JM. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 1991, 65(5):753-763. 10.1016/0092-8674(91)90383-A, 1904009.
21. Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003, 423(6937):302-305. 10.1038/nature01587, 12714971.
22. Raaphorst FM. Self-renewal of hematopoietic and leukemic stem cells: a central role for the Polycomb-group gene Bmi-1. Trends Immunol 2003, 24(10):522-524. 10.1016/S1471-4906(03)00241-2, 14552834.
23. Dick JE. Stem cells: Self-renewal writ in blood. Nature 2003, 423(6937):231-233. 10.1038/423231a, 12748623.
24. Ohta H, Sawada A, Kim JY, Tokimasa S, Nishiguchi S, Humphries RK, Hara J, Takihara Y. Polycomb group gene rae28 is required for sustaining activity of hematopoietic stem cells. J Exp Med 2002, 195(6):759-770. 10.1084/jem.20011911, 2193743, 11901201.
25. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003, 423(6937):255-260. 10.1038/nature01572, 12714970.
26. van der Lugt NM, Domen J, Linders K, van Roon M, Robanus-Maandag E, te Riele H, van der Valk M, Deschamps J, Sofroniew M, van Lohuizen M, Bwrns A. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 1994, 8(7):757-769. 10.1101/gad.8.7.757, 7926765.
27. Iwama A, Oguro H, Negishi M, Kato Y, Morita Y, Tsukui H, Ema H, Kamijo T, Katoh-Fukui Y, Koseki H, van Lohuizen M, Nakauchi H. Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity 2004, 21(6):843-851. 10.1016/j.immuni.2004.11.004, 15589172.
28. Mihara K, Chowdhury M, Nakaju N, Hidani S, Ihara A, Hyodo H, Yasunaga S, Takihara Y, Kimura A. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and patient prognosis. Blood 2006, 107(1):305-308. 10.1182/blood-2005-06-2393, 16160010.
29. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, Fu LW, Huang WL, Dimri GP, Band V, Zeng YX. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 2006, 66(12):6225-6232. 10.1158/0008-5472.CAN-06-0094, 16778197.
30. Stahlman MT, Besnard V, Wert SE, Weaver TE, Dingle S, Xu Y, von Zychlin K, Olson SJ, Whitsett JA. Expression of ABCA3 in developing lung and other tissues. J Histochem Cytochem 2007, 55(1):71-83.
31. Saugstad OD, Hansen TW, Rønnestad A, Nakstad B, Tølløfsrud PA, Reinholt F, Hamvas A, Coles FS, Dean M, Wert SE, Whitsett JA, Nogee LM. Novel mutations in the gene encoding ATP binding cassette protein member A3 (ABCA3) resulting in fatal neonatal lung disease. Acta Paediatr 2007, 96(2):185-190. 10.1111/j.1651-2227.2007.00016.x, 17429902.
32. Chapuy B, Koch R, Radunski U, Corsham S, Cheong N, Inagaki N, Ban N, Wenzel D, Reinhardt D, Zapf A, Schweyer S, Kosari F, Klapper W, Truemper L, Wulf GG. Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestration. Leukemia 2008, 22(8):1576-1586. 10.1038/leu.2008.103, 18463677.
33. Wulf GG, Modlich S, Inagaki N, Reinhardt D, Schroers R, Griesinger F, Trümper L. ABC transporter ABCA3 is expressed in acute myeloid leukemia blast cells and participates in vesicular transport. Haematologica 2004, 89(11):1395-1397.
34. Norwood K, Wang RY, Hirschmann-Jax C, Andreeff M, Brenner MK, Goodell MA, Wulf GG. An in vivo propagated human acute myeloid leukemia expressing ABCA3. Leuk Res 2004, 28(3):295-299. 10.1016/j.leukres.2003.08.006, 14687625.
35. Efferth T, Gillet JP, Sauerbrey A, Zintl F, Bertholet V, de Longueville F, Remacle J, Steinbach D. Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia. Mol Cancer Ther 2006, 5(8):1986-1994. 10.1158/1535-7163.MCT-06-0086, 16928819.
36. Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, Weinhage T, Menck K, Hupfeld T, Koch R, Trümper L, Wulf GG. Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci USA 2011, 108(37):15336-15341. 10.1073/pnas.1102855108, 3174603, 21873242.
37. Lu J, Ma Y, Kong N, Alipio Z, Gao C, Krause DS, Silberstein LE, Chai L. Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemia. Leukemia 2011, 25(7):1211-1213. 10.1038/leu.2011.65, 21468036.
38. Beà S, Tort F, Pinyol M, Puig X, Hernández L, Hernández S, Fernandez PL, van Lohuizen M, Colomer D, Campo E. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 2001, 61(6):2409-2412.
39. Sawa M, Yamamoto K, Yokozawa T, Kiyoi H, Hishida A, Kajiguchi T, Seto M, Kohno A, Kitamura K, Itoh Y, Asou N, Hamajima N, Emi N, Naoe T. BMI-1 is highly expressed in M0-subtype acute myeloid leukemia. Int J Hematol 2005, 82(1):42-47. 10.1532/IJH97.05013, 16105758.
40. Merkerova M, Bruchova H, Kracmarova A, Klamova H, Brdicka R. Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation. Leuk Lymphoma 2007, 48(4):793-801. 10.1080/10428190601186002, 17454639.
41. Zhu W, Huang L, Xu XJ, Qian H, Xu WR. Anti-proliferation effect of BMI-1 in U937 cells with siRNA. Int J Mol Med 2010, 25(6):889-895.
42. Meng XX, Liu WH, Liu DD, Zhao XY, Su BL. Construction of antisense Bmi-1 expression plasmid and its inhibitory effect on K562 cells proliferation. Chin Med J 2005, 118(16):1346-1350.
43. Cui W, Kong NR, Ma YP, Amin HM, Lai R, Chai L. Differential expression of the novel oncogene, SALL4, in lymphoma, plasma cell myeloma, and acute lymphoblastic leukemia. Mod Pathol 2006, 19(12):1585-1592. 10.1038/modpathol.3800694, 16998462.
44. Zhu X, Zhang H, Qian M, Zhao X, Yang W, Wang P, Zhang J, Wang K. The significance of low PU.1 expression in patients with acute promyelocytic leukaemia. J Hematol Oncol 2012, 5:22. 10.1186/1756-8722-5-22, 3407792, 22569057.
45. Steinbach D, Gillet JP, Sauerbrey A, Gruhn B, Dawczynski K, Bertholet V, de Longueville F, Zintl F, Remacle J, Efferth T. ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res 2006, 12(14 Pt 1):4357-4363.
46. Huang X, Chen S, Shen Q, Yang L, Li B, Zhong L, Geng S, Du X, Li Y. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia. J Hematol Oncol 2010, 3:44. 10.1186/1756-8722-3-44, 2992472, 21080944.